Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

In this week’s Phispers, we bring you the split story of two GLP-1 drugmakers — Eli Lilly and Novo Nordisk. While L...

Impressions : 311

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

Public health suffered several setbacks over the last week. First, the United States formally exited the World Health Organiza...

Impressions : 1228

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

In 2022, Pfizer had crossed US$ 100 billion in revenue owing to its Covid products. While that was a one-off, Johnson & Johnson...

Impressions : 1124

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1139

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations

J&J's 2026 sales may cross US$ 100 bn; FDA delays fast-track reviews of drugs under Trump's voucher program

AbbVie inks US$ 5.6 bn oncology deal with China's RemeGen; Astra buys Modella AI to speed up cancer drug research

Vis' Yuvezzi Receives Approval in US

SKG Pharma's Generics Sertraline HCl Receives Approval in US

Eugia Pharma's Generics Mesna Receives Approval in US

Sun Pharm Inds' Generics Deflazacort Receives Approval in US

Mankind Pharma's Generics Propranolol HCl Receives Approval in US

MSN's Generics Metformin HCl Receives Tentative Approval in US

Humanwell's Generics Tapentadol HCl Receives Approval in US

Caplin's Generics Methylprednisolone Receives Approval in US

I 3 Pharms' Generics Tranexamic Acid Receives Approval in US

Aurobindo's Generics Betamethasone Receives Approval in US

FDA Issues Form 483 to InnoStar Bio-Tech Nantong

FDA Issues Form 483 to JKR Pharmacy Ventures

Enforcement Report - Week of January 28, 2026

Center For Immunology's Receives FDA Warning Letter

Fulijaya Manufacturing SDN BHD's Receives FDA Warning Letter

FDA Issues Form 483 to Empower Clinic Services dba Empower Pharma

FDA Issues Form 483 to Denver Solutions

FDA Issues Form 483 to Asahi Kasei Finechem Co.

FDA Issues Form 483 to Petscript

FDA Issues Form 483 to Pine Pharmaceuticals

Evonik sets new dividend policy, meets guidance for 2025

NY to join WHO's global outbreak response network

Biodexa Announces Exclusive License of Otsuka's OPB-171775

AbbVie Reports Full-Year and Q4 2025 Financial Results

Amgen Thumbs-Down on FDA's ask, Tavneos Sales Continue

AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer

Lupin Introduces Topiramate Extended-Release Capsules In US

Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets

Abbvie Seeks FDA & EMA Approval For Upadacitinib

Biologics, biosimilars are the focus of India's $1.1B investment

Lupin Introduces Topiramate Extended-Release Capsules In US

Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets

Lupin Launches Dasatinib Tablets In The United States

Indoco Remedies Gets USFDA Nod To Sell Generic Epilepsy Medicine

Alembic Gets USFDA Nod For Difluprednate Ophthalmic Emulsion

U.S. FDA Accepts Transpire Bio's ANDA for Generic Trelegy Filing

Sun Pharma Receives DCGI Approval For Generic Semaglutide

MNC's Cancer Drug Patent Rejected, Allowing Generics Entry

Aspire Biopharma Files Patent for Sublingual Generic Xanax(R)

SEC Recommends Three Firms For Semaglutide Formulations

Biodexa Announces Exclusive License of Otsuka's OPB-171775

AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer

Abbvie Seeks FDA & EMA Approval For Upadacitinib

Biologics, biosimilars are the focus of India's $1.1B investment

Pfizer Links Monthly GLP-1 To Competitive Weight Loss In Phase 2

Merck lines up $70B+ in revenue opportunities over next decade

Roche Continues RNA Return With $1.7B Deal For Sanegene Drug

Twist Bio Reveals Q1 2026 Financials

Eisai Invests $8.8M In Malaria, Tuberculosis, And NTD R&D Project

Skye Reports Positive Cbeyond Ph 2A Extension Interim Study

Piramal Pharma Solutions Launches Tablet-In-Capsule Services

Lilly Drafts Plan For Last Of 4 New US Drug Manufacturing Plants

FDA Launches Program to Boost Domestic Drug Manufacturing

Wanbury Reveals Tanuku API Facility, Aims For Rs. 100 Crore

Minimum Import Price Set For Penicillin G, Salts

Beyond the Label What Defines Pharma-Grade Mupirocin Calcium API

Siegfried to acquire high-quality small molecules drug substance

Minakem becomes DMF holder for five additional APIs

Korean CDMO ST Pharm Signs $56M Contract For API Production

HRV Pharma, Haleos Labs Partner on Partner on Orphan & niche APIs

AICDF Warns Sanofi India On Trade Policy Changes

EU Body's Advice on Toxin Limit in Baby Formula Prompts Recalls

Doctor Is 1st to Face Private Lawsuit Under Abortion Drug Ban

Aquestive Therapeutics Receives FDA Complete Response Letter

Health Ministry Proposes Pregabalin For Schedule H1 Inclusion

Pondicherry Recalls 3 Batches of Substandard Drugs

Haryana FDA Conducts Large-Scale Raid On Fatehabad Pharmacies

Allopathic Taint Triggers 'X-Plus Gold' Ayurvedic Recall

Drug Misuse: Govt May Curb 'Pregabalin' Sales

Neogen Recalls Neogen Vet HYCOAT Hyaluronate Sodium Nationwide

Spectral AI Joins National Burn Awareness Week 2026

Dandy Revolutionizes Chairside Experience With Dandy Cart Launch

H.H.C. Group Publishes White Paper On Ai-Driven Claims Reviews